Future of the pharmacogenomics of calcineurin inhibitors in renal transplant patients

被引：6
|
作者：
Zhu, Huaijun [1 ]
Ge, Weihong [1 ]
机构：
[1] Nanjing Univ, Affiliated Nanjing Drum Tower Hosp, Sch Med, Dept Pharm, Nanjing 210008, Jiangsu, Peoples R China
来源：
PHARMACOGENOMICS | 2011年 / 12卷 / 11期
关键词：
calcineurin inhibitor; epigenetics; orphan nuclear receptor; pharmacogenomics; renal transplantation; REGULATED GENE-EXPRESSION; RECIPIENTS; THERAPY; PHARMACOKINETICS; PHARMACODYNAMICS; PERSPECTIVES; CELLS; CYP3A;
D O I：
10.2217/PGS.11.129
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：1505 / 1508
页数：4
相关论文
共 50 条
  • [21] Low-density lipoprotein composition and oxidation are not influenced by calcineurin inhibitors in renal transplant patients
    Morena, M
    Vela, C
    Garrigue, V
    Catanzano, J
    Descomps, B
    Cristol, JP
    Mourad, G
    TRANSPLANTATION PROCEEDINGS, 2000, 32 (08) : 2785 - 2786
  • [22] Insulin Requirement After a Renal Transplant in Patients With Type 2 Diabetes: The Choice of Calcineurin Inhibitors
    van den Hoogen, Martijn W. F.
    van der Hoeven, Anna M.
    Hilbrands, Luuk B.
    EXPERIMENTAL AND CLINICAL TRANSPLANTATION, 2013, 11 (03) : 234 - 238
  • [23] Withdrawal of calcineurin inhibitors in liver transplant patients with drug-related renal insufficiency.
    Stieber, AC
    Smallwood, GA
    Davis, LP
    Heffron, TG
    HEPATOLOGY, 1999, 30 (04) : 184A - 184A
  • [24] Characterizing the interaction between mycophenolate mofetyl and calcineurin inhibitors in renal transplant patients by pharmacokinetic modelling
    Cremers, S
    Schoemaker, R
    Scholten, E
    den Hartigh, J
    van Kan, E
    Guchelaar, HJ
    Paul, L
    de Fijter, J
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2005, 59 (01) : 124 - 125
  • [25] VITAMIN D IN PAEDIATRIC RENAL TRANSPLANT RECIPIENTS: INTERACTION WITH CALCINEURIN INHIBITORS?
    Prytula, A. A.
    Bouts, A. H.
    van Gorkom, M.
    Dorresteijn, E.
    Cransberg, K.
    ACTA CLINICA BELGICA, 2013, 68 (04): : 318 - 318
  • [26] The influence of calcineurin inhibitors on pulse wave velocity in renal transplant recipients
    Strozecki, Pawel
    Adamowicz, Andrzej
    Wlodarczyk, Zbigniew
    Manitius, Jacek
    RENAL FAILURE, 2007, 29 (06) : 679 - 684
  • [27] Choice of calcineurin inhibitors in adult renal transplantation: effects on transplant outcomes
    Pilmore, Helen
    NEPHROLOGY, 2007, 12 : S88 - S97
  • [28] Association of Hearing Loss and Calcineurin Inhibitors in Pediatric Renal Transplant Recipients
    Gulleroglu, K.
    Baskin, E.
    Aydin, E.
    Bayrakci, U.
    Sevmis, S.
    Melek, E.
    Ozluoglu, L.
    Karakayali, H.
    Haberal, M.
    PEDIATRIC NEPHROLOGY, 2010, 25 (09) : 1813 - 1813
  • [29] Long-term results after conversion from calcineurin inhibitors to sirolimus in renal transplant patients
    Martinez-Mier, Gustavo
    Avila-Pardo, Sandro F.
    Mendez-Lopez, Marco T.
    Budar-Fernandez, Luis F.
    CLINICAL TRANSPLANTATION, 2010, 24 (04) : 467 - 473
  • [30] Efficacy and Safety of Mycophenolate Mofetil Monotherapy in Liver Transplant Patients With Renal Failure Induced by Calcineurin Inhibitors
    Barrera Pulido, L.
    Alamo Martinez, J. M.
    Pareja Ciuro, F.
    Gomez Bravo, M. A.
    Serrano Diez-Canedo, J.
    Bernal Bellido, C.
    Suarez Artacho, G.
    Garcia Gonzalez, I.
    Pascasio Acevedo, J. M.
    Bernardos Rodriguez, A.
    TRANSPLANTATION PROCEEDINGS, 2008, 40 (09) : 2985 - 2987
12345